SATURDAY, OCTOBER 1, 2016

Senegal introduces two new vaccines to protect children

The GAVI Alliance announced on Tuesday that Senegal has added two new vaccines to its routine immunization schedule to protect its children against pneumonia, rubella and the measles.

The pneumococcal and measles-rubella vaccines were added to Senegal's routine immunizations with the help of the GAVI Alliance's Advance Market Commitment program, which incentivizes vaccine manufacturers to produce larger quantities of vaccines for use in the developing world.

"These introductions are very important for Senegal because children are dying every day from these vaccine-preventable diseases," Senegal Health Minister Awa Marie Coll Seck said. "I am happy that we have been able to introduce these vaccines for our children with GAVI Alliance support."

Pneumococcal disease is one of the leading causes of pneumonia, a preventable disease that is responsible for the most deaths in children under five years old among vaccine-preventable diseases. Measles is responsible for approximately 160,000 deaths each year and rubella can cause serious harm to a mother's unborn child, including deafness and death.

"Senegal is investing in the health of its children by protecting them from these three potentially fatal diseases," Gavi Alliance CEO Dr. Seth Berkley said. "We want to see children benefiting from the power of vaccines no matter where in the world they live."

The pneumococcal vaccine is being implemented into the immunization program immediately. The measles-rubella vaccine will be implemented at the beginning of 2014.

 

Pneumococcal disease is one of the leading causes of pneumonia, a preventable disease which is responsible for the most deaths in children under five years old among vaccine-preventable diseases. The measles is responsible for approximately 160,000 deaths each year and Rubella can cause serious harm to a mother's unborn child, including deafness and death.

"Senegal is investing in the health of its children by protecting them from these three potentially fatal diseases," CEO of the GAVI Alliance Dr. Seth Berkley said. "We want to see children benefitting from the power of vaccines no matter where in the world they live."

The pneumococcal vaccine will be implemented into the immunization program immediately. The measles-rubella vaccine will be implemented at the beginning of 2014.